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Background. Elevated middle cerebral artery peak systolic velocity (MCA-PSV) has been reported in nonanemic fetuses following
fetal transfusion, and has been attributed to a major population of red blood cells (RBCs) with an adult mean corpuscular volume
(MCV)inthefetalcirculation.ReportedhereisananalogouscaseofelevatedMCA-PSVwithanormalfetalhematocritandrelative
fetal microcytosis due to fetal α-thalassemia trait. Case. Ultrasound ﬁndings concerning for early hydrops prompted measurement
of MCA-PSV, which was elevated. Cordocentesis revealed fetal microcytosis with a normal hematocrit which proved to be due to
fetal α-thalassemia trait inherited from the mother. Conclusion. This case provides another example of elevated MCA-PSV with
normal hematocrit and microcytosis, here due to fetal α-thalassemia trait. This ﬁnding provides support for the observation that
MCA-PSV may be inﬂuenced by hematological indices other than the fetal hematocrit.
Copyright © 2009 Kent Heyborne. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
Measurement of the middle cerebral artery peak systolic
velocity (MCA-PSV) has become the mainstay for the
detection of fetal anemia. It has been shown that MCA-PSV
measurements may be increased in nonanemic fetuses with a
signiﬁcant population of adult RBC following multiple fetal
transfusions [1–3]. While the sensitivity of the PSV measure-
ment remains high, the false-positive rate may increase with
an increasing number of transfusions. We present here an
analogouscircumstanceofelevatedMCA-PSVwithanormal
hematocrit due to relative fetal microcytosis secondary to α-
thalassemia trait.
2.Case
The patient was a 36-year-old gravida 2 para 1 woman
of Filipino descent with dichorionic twins following in
vitro fertilization and embryo transfer. She was noted to
have a microcytic anemia at her ﬁrst prenatal visit (hema-
tocrit 27.3%, MCV 72fL). Hemoglobin electrophoresis was
consistent with α-thalassemia trait. Her husband did not
have a hemoglobinopathy. An ultrasound at 13 weeks 4
days gestation revealed modestly elevated nuchal thickness
(NT) measurements of 3.5 and 3.3mm for twins A and B,
respectively, prompting amniocentesis at 16 weeks gestation.
Normal 46, XX karyotypes were found for both twins.
Due to the twin gestation and the known increased risks
for fetal pathology in euploid fetuses with increased NT
measurements, serial ultrasounds were performed. At 30
weeks gestation prominent fetal bowel and possible mild
ascites were noted on twin B. MCA-PSV on twin B was
signiﬁcantly elevated at 64cm/s (1.60MOM) corresponding
to a hematocrit of 24% [4]. MCA-PSV for twin A was
normal. Careful follow-up was elected, and fetal testing
was reassuring. At 33 weeks 2 days gestation the ﬁnding
of possible mild ascites had resolved but the MCA-PSV
remained elevated at 73cm/s (1.57MOM) corresponding
to a hematocrit of 24.9% [4]. Cordocentesis was elected
to help with delivery planning and due to concern for
potential fetal jeopardy due to unexplained anemia. Due
to the late gestation and placental topology it was diﬃcult
to determine with certainty which placental cord insertion
belonged to each twin, and so both were sampled. The
ﬁndings are tabulated in Table 1. It was concluded that the
relative microcytosis in twin B (93.3fL, normal for 33 weeks
= 113.6fL) [5] most likely explained the falsely elevated
MCA-PSV measurements, and was presumed secondary to
α-thalassemia trait in that twin. The patient was managed
expectantly, and spontaneously delivered uneventfully at2 Obstetrics and Gynecology International
Table 1: Maternal and fetal hematocrit and MCV values.
Hematocrit (%) MCV (fL)
Maternal 25.5 73.5
Twin A 40.1 109.8
Twin B 36.3 93.3
36 weeks. Hemoglobin electrophoresis for twin B done at
4 months of age was consistent with α-thalassemia trait
(HbA 91.6%, HbA2 1.9%, HbF 6.5%). Both children were
otherwise well at that time.
3. Comment
Alpha-thalassemia trait results from deletion of two of the
four α globin genes, resulting in deﬁcient α chain production
and an associated microcytic anemia. In people of Asian
ethnicity, the two missing α genes are typically arranged in
cis (αα/−−), resulting in transmission of the trait to 50% of
oﬀspring.
In this case, serial ultrasounds led to a question of
mild ascites and the ﬁnding of abnormal MCA Doppler
velocimetry. In retrospect, it seems likely that the possible
mild ascites was an artifact of heightened scrutiny related
to the increased NT measurements. The abnormal MCA
Doppler studies resulted in a concern for fetal anemia and
possible fetal jeopardy and it was elected to obtain fetal
hematocrits to guide further management. Cordocenteses
wrer performed on both twins for technical reasons as
discussed, providing a normal control for the abnormal
results from twin B. The MCV on twin B was midway
betweenthenormalfetalMCVontwinAandtheabnormally
low MCV on the patient, and was in the normal range for
adult hemoglobin.
This case provides a “natural experiment” conﬁrming
that MCA-PSV measurements may be raised by the presence
of red blood cells with an adult MCV despite a normal
hematocrit, as observed in fetuses that have been transfused
with adult blood. In the case of elevated MCA-PSV resulted
following fetal transfusion of adult RBC, the increased
MCA-PSV measurements have been attributed to reduced
posttransfusion viscosity due to both the smaller size of the
transfused adult RBC and reduced cellular rigidity of adult
RBC [6, 7]. Our results support the conclusion that the
elevated MCA-PSV may be due to reduced MCV. Any role
foralteredcellmembranecharacteristics(duetointracellular
accumulation of abnormal hemoglobin, e.g.,) is less clear.
Fetal α-thalassemia trait, and presumably other hemo-
globinopathies resulting in relative fetal microcytosis, should
be considered when unexpectedly elevated MCA-PSV results
are obtained.
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